Caitong International Asset Management Co., LTD Edgewise Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 2,053 shares of EWTX stock, worth $52,125. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,053
Previous 2,053
-0.0%
Holding current value
$52,125
Previous $54.8 Million
-0.0%
% of portfolio
0.05%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
212Shares Held
101MCall Options Held
1.23MPut Options Held
416K-
Orbimed Advisors LLC San Diego, CA15MShares$381 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$226 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$156 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$153 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$127 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.6B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...